UNITED STATES NEWS

FDA unlikely to rule on Merck’s COVID pill before December

Oct 14, 2021, 8:00 PM
This undated image provided by Merck & Co. shows their new antiviral medication. The drugmaker has ...

This undated image provided by Merck & Co. shows their new antiviral medication. The drugmaker has said its experimental pill for people sick with COVID-19 reduced hospitalizations and deaths. The U.S. Food and Drug Administration will ask its outside experts to review Merck's pill to treat COVID-19 at a meeting in late November. Regulators announced the November 30 meeting on Thursday, Oct. 14, 2021 signaling they will conduct a detailed review of the drug's safety and effectiveness. (Merck & Co. via AP)

(Merck & Co. via AP)

WASHINGTON (AP) — The Food and Drug Administration said Thursday it will ask its outside experts to meet in late November to scrutinize Merck’s pill to treat COVID-19.

The Nov. 30 meeting means U.S. regulators almost certainly won’t issue a decision on the drug until December, signaling that the agency will conduct a detailed review of the experimental treatment’s safety and effectiveness. The panelists are likely to vote on whether Merck’s drug should be approved, though the FDA is not required to follow their advice.

It marks the first time the FDA has convened its expert advisers before ruling on a coronavirus treatment. Advisory committee meetings have become a standard part of its process for reviewing vaccines.

The agency decided to convene the meeting to help inform its decision-making, its top drug regulator said in a statement.

“We believe that, in this instance, a public discussion of these data with the agency’s advisory committee will help ensure clear understanding of the scientific data and information that the FDA is evaluating,” said Dr. Patrizia Cavazzoni, director of FDA’s drug center.

The FDA said the meeting was scheduled as soon as possible following Merck’s request. The November date will allow agency scientists to review the application ahead of the meeting, the agency said.

Merck and its partner Ridgeback Biotherapeutic filed their FDA application on Monday, asking the agency to grant emergency use for adults with mild to moderate COVID-19 who are at risk for severe disease or hospitalization. That is roughly the same indication as available infusion drugs.

Three IV antibody drugs have been authorized since last year to cut COVID-19 hospitalization and death, but they are expensive, hard to produce and require specialty equipment and health professionals to deliver. If authorized, Merck’s drug, molnupiravir, would be the first that patients could take at home to ease symptoms and speed recovery.

The company announced preliminary results earlier this month showing its drug cut hospitalizations and deaths by half among patients with early COVID-19 symptoms. The results have not yet been peer-reviewed, the standard practice for vetting such research.

The company also has not disclosed details on molnupiravir’s side effects, except to say that rates of those problems were similar between people who got the drug and those who received dummy pills.

If authorized, Merck’s drug is likely to be the first — but not the only — pill to treat COVID-19. Pfizer, Roche and Appili Therapeutics are each studying similar drugs and are expected to report results in the coming weeks and months.

___

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

United States News

Associated Press

Today in History

Today in History Today is Sunday, Jan. 23, the 23rd day of 2022. There are 342 days left in the year. Today’s Highlight in History: On Jan. 23, 2020, Chinese state media said the city of Wuhan would be shutting down outbound flights and trains, trying to halt the spread of a new virus that […]
24 hours ago
Associated Press

Fake ambulance with 28 migrants aboard found in Mexico

MEXICO CITY (AP) — Mexican authorities have detected many strange schemes to smuggle Central American migrants to the U.S. border, but on Saturday they said they found a new one: a fake ambulance loaded with 28 Nicaraguans, including nine unaccompanied children. Mexico’s Interior Department said the vehicle had been painted with fake logos from a […]
24 hours ago
Associated Press

With new AG, Virginia takes new position on abortion case

RICHMOND, Va. (AP) — Virginia’s new attorney general has altered the state’s position on a closely watched abortion case before the U.S. Supreme Court, with his office now saying it should be left to individual states to decide on restrictions. When Democrat Mark Herring was attorney general, the state joined more than 20 other states […]
24 hours ago
Associated Press

Arnold Schwarzenegger ‘fine’ following four-car crash in LA

LOS ANGELES (AP) — A spokesman said Arnold Schwarzenegger was fine after being involved in a car crash that sent a woman to the hospital with minor injuries. The 74-year-old actor and former California governor was driving a GMC Yukon that was among four vehicles involved in Friday’s wreck in the Brentwood section of Los […]
24 hours ago
FILE - Mexican President Andres Manuel Lopez Obrador greets the crowd at a rally to commemorate his...
Associated Press

Mexico’s energy reform strains ties with US

MEXICO CITY (AP) — Mexico’s plan to favor its own state-owned electrical power plants and limit energy sales by private, foreign-built projects could affect U.S. investment in Mexico, officials said during bilateral talks this week. According to statements issued Friday, the U.S. government has “real concerns with the potential negative impact” on U.S. firms and […]
24 hours ago
Associated Press

Maryland school shooting: Teen faces attempted murder charge

GAITHERSBURG, Md. (AP) — A 17-year-old was being held without bond Saturday on charges including attempted second-degree murder in connection with the shooting of a fellow student at a high school in a Maryland suburb of the nation’s capital, authorities said. The suspect, Steven Alston Jr., was taken into custody about two hours after officers […]
24 hours ago

Sponsored Articles

...
ENVOQUE MD

Thyroid issues: Here are the warning signs and what to do

In a 100-person office in the United States, an estimated 12 co-workers, employees and loved ones, will likely develop a thyroid condition during their lifetime. That’s because, according to the American Thyroid Association, more than 12% of the U.S. population will experience thyroid issues.
...
Sanderson Ford

Sanderson Ford offers cars and deals for all this holiday season

Sanderson Ford’s No! Vember Black Friday sale is giving an opportunity to purchase a new 2021 vehicle just in time for the holiday season.
...
DISC DESERT INSTITUTE FOR SPINE CARE

What you need to know about spine health

With 540 million people suffering from lower back pain, it remains the leading cause of long-term disability. That’s why World Spine Day on Oct. 16 will raise awareness about spinal health with its theme, BACK2BACK. “BACK2BACK will focus on highlighting ways in which people can help their spines by staying mobile, avoiding physical inactivity, not overloading […]
FDA unlikely to rule on Merck’s COVID pill before December